Statistics
Total Visits
Views | |
---|---|
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models(legacy) | 132 |
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models(legacy) | 107 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models | 2 | 13 | 1 | 3 | 0 | 9 | 1 |
File Downloads
Views | |
---|---|
hdl_100143.pdf(legacy) | 94 |
hdl_100143.pdf | 82 |
Top Country Views
Views | |
---|---|
United States | 102 |
Australia | 50 |
China | 26 |
France | 17 |
Netherlands | 8 |
Vietnam | 8 |
Spain | 3 |
United Kingdom | 3 |
Germany | 2 |
Brazil | 1 |
Top City Views
Views | |
---|---|
Kaleen | 31 |
Ashburn | 19 |
Fairfield | 17 |
Hanoi | 8 |
Rotterdam | 8 |
Des Moines | 6 |
Adelaide | 5 |
Buffalo | 5 |
San Ramon | 5 |
Boardman | 4 |